Compare Pfizer Inc (PFE) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs TotalEnergies SE — how do they compare? Pfizer Inc trades at $28.24 (market cap $158.56B), while TotalEnergies SE trades at $86.42 (market cap $191.82B). The key difference: TotalEnergies SE is the larger of the two by market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and TotalEnergies SE for 90 Days on average.
| PFE | TTE | |
|---|---|---|
Market Cap | $158.56B | $191.82B |
Volume | 44,138,282 | 3,311,339 |
Sector | Health | Energy |
52-Week High | $29.02 | $93.60 |
52-Week Low | $23.67 | $57.39 |
Typical Hold Time | 158 Days | 90 Days |
Enterprise Value | $210.06B | $222.81B |
Dividend Yield | 6.18% | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
TotalEnergies SE (TTE) trades at $86.11, up 2.23% today, with a bearish technical signal but strong fundamentals including a P/E of 10.77 and net income margin of 9.08%. Recent earnings show beats in Q1 and Q2 2026, while Q4 2025 missed expectations. The company announced a $10 billion investment in Argentina and increased share buybacks to $2.5 billion, signaling growth commitment amid stable cash flows.
The outlook is positive with a consensus price target of $95.33, representing 10.7% upside, supported by 55.88% analyst buy ratings. Risks include revenue declines from $263.3B in 2022 to $182.3B in 2025 and geopolitical exposure, but diversification and dividend growth plans offer resilience for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
